Dr. Vogel to Lead Joint Breast Cancer Program

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 3
Volume 5
Issue 3

PITTSBURGH--Victor Vogel, MD, MHS, will lead a newly established joint breast cancer program of the University of Pittsburgh Cancer Institute and Magee-Womens Hospital. He will also join the University of Pittsburgh as professor of medicine and epidemiology.

PITTSBURGH--Victor Vogel, MD, MHS, will lead a newly establishedjoint breast cancer program of the University of Pittsburgh CancerInstitute and Magee-Womens Hospital. He will also join the Universityof Pittsburgh as professor of medicine and epidemiology.

Dr. Vogel comes to Pittsburgh from the University of Texas M.D.Anderson Cancer Center, where he was responsible for recruitingthe largest number of women onto the Breast Cancer PreventionTrial, the national study designed to determine the value of tamoxifen(Nolva-dex) in preventing breast cancer in high-risk women.

"One of the program's most important missions," Dr.Vogel said, "will be to enhance delivery of care to womenwho face barriers, ie, older women or those who are poor or livein rural areas."

Recent Videos
Regardless of disease burden or disease progression speed on front-line therapy, trastuzumab deruxtecan appears effective in HER2-low breast cancer.
Performance status, age, and comorbidities may impact benefit seen with immunotherapy vs chemotherapy in patients with breast cancer.
Related Content